NDS® Probiotic Barrier
NDS® Probiotic Barrier has been developed
in collaboration with Wageningen University and Hospital Gelderse Vallei in Ede, the Netherlands. It is a multispecies probiotic product specifically developed to strengthen and improve the intestinal barrier function. The bacterial strains of NDS® Probiotic Barrier have been selected for their capacity to
Strengthen the intestinal barrier
Positively influence the immune system
Application – Strengthening the intestinal barrier function
Product Quality – Bacterial strains combined with using a Unique BioactiveTM technology that ensures biological activity, gastro-intestinal survival and stability of the probiotic strains.
CFU (Colony Forming Units) – 5 x 109 cfU/gram
NDS® Probiotic Barrier has been tested in a pilot study with migraine patients in collabora- tion with Wageningen University and Hospital Gelderse Vallei in Ede, the Netherlands3. Migraine is an inflammatory disorder in wich an increased intestinal permeability seems to play a role. Twenty-seven migraine patients received a daily dose of NDS® Probiotic Barrier (5 x 109 cfu/day) for 12 weeks. Patients kept
a headache diary and filled in two validated headache questionnaires at the start and the end of the intervention period. The trial showed that supplementation with NDS® Probiotic Bar- rier significantly decreased migraine frequency with 23% after 5 weeks (figure 3). at the end of the treatment period the self reported intensity of migraine significantly decreased with 13% (figure 4). These results show that supplemen- tation with NDS® Probiotic Barrier can alleviate migraine by strengthening the intestinal barrier function.
Food supplements should not be used as a substitute for a diversified diet.
These products are not intended to diagnose, treat, cure, or prevent any disease.